Posted on 7/17/18
RSC Solutions Launches RSC Healthcare LLC, Expands Footprint In Healthcare Industry
RSC Solutions, a leading technology services company, today announced the launch of its healthcare staffing division under the banner of RSC Healthcare LLC. RSC Healthcare LLC . . .
Posted on 7/17/18
Johnson & Johnson Reports 2018 Second-Quarter Results
Johnson & Johnson (NYSE: JNJ) today announced sales of $20.8 billion for the second quarter of 2018, an increase of 10.6% as compared to the second . . .
Posted on 7/17/18
Pfizer's Reorganizing Again. Is Its Stock a Buy Now?
Last week, Pfizer (NYSE:PFE) announced that it was splitting its operating segments into three divisions. The company presently operates under a two-unit system: Innovative Health and . . .
Posted on 7/17/18
Aquestive Therapeutics Readies $60 Million IPO
Quick TakeAquestive Therapeutics (AQST) intends to raise $60 million in an IPO of its common stock, according to an amended registration statement.The company is advancing a . . .
Posted on 7/17/18
Targeted Oncology Partners with The International Liver Cancer Association
CRANBURY, N.J.--(BUSINESS WIRE)--Targeted Oncology™, a print and digital resource that offers content and expert opinions on precision medicine in oncology, becomes partners with the International Liver . . .
Posted on 7/16/18
Court Ruling in Favor of Aquestive Therapeutics Enjoining Dr. Reddy's Laboratories from Launching its Generic Suboxone Product
Aquestive Therapeutics announces today that the U.S. District Court for the District of New Jersey has granted Aquestive together with Indivior PLC (LON: INDV) and its U.S. . . .
Posted on 7/16/18
Cognizant Leads the Pack in Life Sciences Digital Services According to New Everest Group Assessment
Cognizant has been named one of the top providers of digital services for life sciences organizations in a new PEAK Matrix report by consulting and research . . .
Posted on 7/16/18
Better Buy: Amgen Inc. vs. Johnson & Johnson
It's a big drugmaker with a blockbuster immunology drug as its top-selling product. It pays an attractive dividend. And it faces some uncertainties. This description fits . . .
Posted on 7/16/18
Pfizer Is Not An All-Powerful Price-Hiker
For a supposedly greedy, all-powerful, price-hiking Big Pharma megacap, Pfizer's (PFE) stock sure isn't doing too well over the long term. There seems to be this . . .
Posted on 7/16/18
Johnson & Johnson Is Recovering From Talcum Powder Correction, Faces Earnings
Johnson & Johnson (NYSE:JNJ) is an iconic and diverse health care giant and a component of the Dow Jones Industrial Average. The stock is down 9.9% . . .
Posted on 7/16/18
Johnson & Johnson: Floodgates And Tidal Waves
Watching an 80-foot wave break at Nazaré, Portugal. (via YouTube).Tidal Waves And FloodgatesLast August, the Financial Times warned that a "tidal wave" of opioid-related lawsuits was . . .
Posted on 7/16/18
Why Celgene Corporation Lost 23.9% of Its Value Halfway Through 2018
What happenedShares of blue-chip biotech Celgene Corporation (NASDAQ:CELG) fell by a staggering 23.9% through the first six months of this year, according to data from S&P . . .
Posted on 7/16/18
Here's How Teva Pharmaceuticals Pulled Off a 28.3% Gain in the First Half of 2018
What happenedShares of Teva Pharmaceutical Industries (NYSE:TEVA), the world's largest producer of generic drugs, rose 28.3% in the first half of 2018, according to data from . . .
Posted on 7/13/18
J&J Slammed With $4.69B Jury Verdict In Missouri Cancer Case
The Missouri jury that awarded $550M to 22 women and their families who blamed ovarian cancer cases on asbestos in Johnson & Johnson's (NYSE:JNJ) talc-based products . . .
Posted on 7/13/18
Why Johnson & Johnson Stock Has Lost 13% So Far in 2018
What happenedShares of healthcare titan Johnson & Johnson (NYSE:JNJ) trailed the market through the first six months of 2018 by shedding 13%, compared to a 2% . . .
Posted on 7/12/18
OhioHealth and Select Medical Expand Joint Venture to Operate Physical Therapy Centers in Central Ohio
Select Medical today announced an expansion of its joint venture agreement with OhioHealth to combine operations of 38 physical therapy centers throughout Central Ohio. The partnership . . .
Posted on 7/12/18
Navitas Life Sciences Named as a Leader in IDC MarketScape
Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions and a full service Clinical, Regulatory & Safety solutions and services provider today announced that it . . .
Posted on 7/12/18
Aquestive Therapeutics Files For $69 Million U.S. IPO
Quick TakeAquestive Therapeutics (AQST) intends to raise gross proceeds of $69 million from a U.S. IPO, according to an S-1 registration statement.The firm is a specialty . . .
Posted on 7/12/18
4 Things You Need to Know About Pfizer's Restructuring Plans
Pfizer (NYSE:PFE) was in the news Wednesday for a second day in a row. On Tuesday, the company announced that it was holding off on price . . .
Posted on 7/11/18
Celgene: Fears Are Overplayed
Any company buying back a lot of stock always catches my attention. A stock has to be cheap and the balance sheet strong in order for . . .
Posted on 7/16/18
InstaMed Joins Epic App Orchard With New Patient Payment Integration
PHILADELPHIA & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--InstaMed announced today that InstaMed External Payment Page Integration is available in the Epic App Orchard, and Boston Medical Center (BMC) . . .
Posted on 7/10/18
Why CTI BioPharma, PetMed Express, and Pfizer Slumped Today
Major market benchmarks extended Friday's gains on Monday, as investors ignored continued trade tensions to instead look forward to the start of a potentially strong corporate . . .
Posted on 7/10/18
Azalea Health Announces Partnership with Iron Bridge for All Public Health Submissions
ATLANTA & PITTSBURGH--(BUSINESS WIRE)--Azalea Health, a leading provider of fully-integrated cloud-based healthcare solutions and services, today announced it has partnered with Iron Bridge Corporation (“Iron Bridge”) . . .
Posted on 7/9/18
NIH and Matinas BioPharma Announce Research Collaboration
BEDMINSTER, N.J. and WASHINGTON, July 09, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative medicines using . . .
Posted on 7/9/18
Citius Provides Clinical Update And Progress Of The Mino-Lok Phase 3 Trial
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided a status report on the progress . . .

